Collector
Giriş Yap
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying | Collector
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.

Go to News Site